Asthmapolis Announces Secondary Funding

6-8-2013 8-50-48 PM

Madison, WI-based Asthmapolis announces that it has received a second investment by the California HealthCare Foundation, bringing CHCF’s total investment in Asthmapolis to more than $1 million. This additional funding comes just two months after the startup closed a Series A round worth $5 million.

Asthmapolis is a medical device that is designed to educate asthma sufferers by educating them on where and why they have attacks. Asthmapolis combines has created a location sensor that attaches to a patients inhaler and records GPS locations, as well as time of day and other environmental data every time an inhaler is used. This information is transmitted to a smartphone app where individuals can begin to understand what causes their asthma attacks.

"We need patients to tell us about the severity of their symptoms, how often they have sudden attacks, and what triggers their attacks so we can modify their treatment plans accordingly. With the Asthmapolis sensor and software application the patient’s inhaler becomes a diary—recording, analyzing and reporting data in real time—which helps providers monitor their patients and helps patients practice informed self-management." – Dr. Rajan Merchant, an allergy, asthma and clinical immunology specialist at Dignity Health.

Asthmapolis received FDA clearance for their platform in July of 2012 and has since contracted with WellPoint, New York-based Wyckoff Heights Medical Center, and Dignity Health in California.

↑ Back to top

Founding Sponsors

Platinum Sponsors